Clinical Trial Update: Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) [Phase 2]

View source ↗

Summary

Phase II study evaluating an improved film-coated tablet formulation of deferasirox for chronic iron overload due to transfusion-dependent anemias; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Transfusion-dependent Anemias

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Iron Overload Due to Transfusion-dependant Anemias | Phase 2 | Status: COMPLETED | Results posted: 2016-10-18